This wee on IPWatchdog Unleashed we have a conversation with Corey Salsberg, who is the Vice President and Global Head of IP Affairs for Novartis, one of the world’s leading and more innovative biopharmaceutical companies. During a wide ranging conversation that goes for just over an hour, we discuss whether patents are to blame for high drug prices, and if not what is the real driver of drug prices in America. Ultimately, the conclusion is there are several things to blame, but placing blame on patents and exclusive rights is misguided and naive.
